Pax-2 and N-myc regulate epithelial cell proliferation and apoptosis in a positive autocrine feedback loop

[1]  J. Ingelfinger,et al.  Reactive oxygen species and nuclear factor-kappa B pathway mediate high glucose-induced Pax-2 gene expression in mouse embryonic mesenchymal epithelial cells and kidney explants. , 2006, Kidney international.

[2]  M. Eccles,et al.  Suppression of ureteric bud apoptosis rescues nephron endowment and adult renal function in Pax2 mutant mice. , 2006, Journal of the American Society of Nephrology : JASN.

[3]  J. Pelletier,et al.  PAX2 Activates WNT4 Expression during Mammalian Kidney Development* , 2006, Journal of Biological Chemistry.

[4]  P. Xie,et al.  Renal-specific oxidoreductase biphasic expression under high glucose ambience during fetal versus neonatal development. , 2005, Kidney international.

[5]  G. Hawthorne.  Preconception care in diabetes. , 2005, Seminars in fetal & neonatal medicine.

[6]  J. Ingelfinger,et al.  Up-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxin. , 2005, Kidney international.

[7]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[8]  P. Xie,et al.  Hyperglycemia: its imminent effects on mammalian nephrogenesis , 2005, Pediatric Nephrology.

[9]  A. Dziarmaga,et al.  Renal hypoplasia: lessons from Pax2 , 2005, Pediatric Nephrology.

[10]  J. Ingelfinger,et al.  Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: impact on proliferation and apoptosis. , 2004, Kidney international.

[11]  I. G. Fantus,et al.  Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells. , 2004, The Journal of endocrinology.

[12]  D. Kylarová,et al.  The detection of myc proteins in the developing human kidney. , 2004, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[13]  J. Ingelfinger,et al.  Angiotensin II increases Pax-2 expression in fetal kidney cells via the AT2 receptor. , 2004, Journal of the American Society of Nephrology : JASN.

[14]  J. Julien,et al.  Ureteric bud apoptosis and renal hypoplasia in transgenic PAX2-Bax fetal mice mimics the renal-coloboma syndrome. , 2003, Journal of the American Society of Nephrology : JASN.

[15]  M. Eccles,et al.  Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival , 2003, Oncogene.

[16]  R. Fine,et al.  Chronic renal insufficiency in children: The 2001 Annual Report of the NAPRTCS , 2003, Pediatric Nephrology.

[17]  G. Ardissino,et al.  Epidemiology of chronic renal failure in children: data from the ItalKid project. , 2003, Pediatrics.

[18]  Y. Nojima,et al.  Involvement of Pax-2 in the action of activin A on tubular cell regeneration. , 2002, Journal of the American Society of Nephrology : JASN.

[19]  M. Busslinger,et al.  Nephric lineage specification by Pax2 and Pax8. , 2002, Genes & development.

[20]  N. Rosenblum,et al.  The molecular control of renal branching morphogenesis: current knowledge and emerging insights. , 2002, Differentiation; research in biological diversity.

[21]  J. Ingelfinger,et al.  High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. , 2002, Endocrinology.

[22]  D. Witte,et al.  Microarray analysis of novel cell lines representing two stages of metanephric mesenchyme differentiation , 2002, Mechanisms of Development.

[23]  R. Kumar,et al.  PAX genes in development and disease: the role of PAX2 in urogenital tract development. , 2002, The International journal of developmental biology.

[24]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[25]  G. Dressler,et al.  Regulation of ureteric bud outgrowth by Pax2-dependent activation of the glial derived neurotrophic factor gene. , 2001, Development.

[26]  J. Duong van Huyen,et al.  Altered nephrogenesis due to maternal diabetes is associated with increased expression of IGF-II/mannose-6-phosphate receptor in the fetal kidney. , 2001, Diabetes.

[27]  S. Lyonnet,et al.  PAX2 mutations in oligomeganephronia. , 2001, Kidney international.

[28]  M. Eccles,et al.  PAX2 suppresses apoptosis in renal collecting duct cells. , 2000, The American journal of pathology.

[29]  J. Rossant,et al.  Role of N-myc in the developing mouse kidney. , 2000, Developmental biology.

[30]  H. Cunliffe,et al.  Primary renal hypoplasia in humans and mice with PAX2 mutations: evidence of increased apoptosis in fetal kidneys of Pax2(1Neu) +/- mutant mice. , 2000, Human molecular genetics.

[31]  N. Rosenblum,et al.  The malformed kidney: disruption of glomerular and tubular development , 1999, Clinical genetics.

[32]  M. Kretzler,et al.  Re-expression of the developmental gene Pax-2 during experimental acute tubular necrosis in mice 1. , 1999, Kidney international.

[33]  権藤 洋一,et al.  Neuronal apoptosis inhibitory protein(NAIP)の発現とプロセシング , 1998 .

[34]  M. Eccles.  The role of PAX2 in normal and abnormal development of the urinary tract , 1998, Pediatric Nephrology.

[35]  B. Brenner,et al.  Nephron mass as a risk factor for progression of renal disease. , 1997, Kidney international. Supplement.

[36]  A. Woolf,et al.  Multiple causes of human kidney malformations , 1997, Archives of disease in childhood.

[37]  S. Lynch,et al.  Sirenomelia, limb reduction defects, cardiovascular malformation, renal agenesis in an infant born to a diabetic mother , 1997, Clinical dysmorphology.

[38]  B. Brenner,et al.  Congenital oligonephropathy: The fetal flaw in essential hypertension? , 1996, Kidney international. Supplement.

[39]  R. Odicasandulache.  The mouse Pax2 1Neu mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney , 1996 .

[40]  P. Gruss,et al.  Pax-2 controls multiple steps of urogenital development. , 1995, Development.

[41]  J. Gnarra,et al.  Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. , 1995, Cancer research.

[42]  B. Brenner,et al.  Fewer nephrons at birth: a missing link in the etiology of essential hypertension? , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  G. Dressler,et al.  The regulation of kidney development: new insights from an old model. , 1994, Current opinion in genetics & development.

[44]  J. Wilkinson,et al.  Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities , 1993, Nature.

[45]  L. Gavin,et al.  Preconception care of diabetes. Glycemic control prevents congenital anomalies. , 1991, JAMA.

[46]  P. Gruss,et al.  Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. , 1990, Development.

[47]  S. Ma,et al.  Tissue and age specific expression of the myc proto-oncogene family throughout the life span of the C57BL/6J mouse strain. , 1989, Oncogene.

[48]  B. Brenner,et al.  Glomeruli and blood pressure. Less of one, more the other? , 1988, American journal of hypertension.

[49]  S. Sakiyama,et al.  Nucleotide sequence of a full-length cDNA for mouse cytosketetal β-actin raRNA , 1986 .

[50]  S. Sakiyama,et al.  Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA. , 1986, Nucleic acids research.

[51]  J. Malins,et al.  Congenital malformations in infants of diabetic mothers. , 1976, The Quarterly journal of medicine.